Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________________________________________________________ FORM 10-Q ____________________________________________________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1 ...

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q4 2021 Results Earnings Conference Call February 25, 2022 4:30 PM ET Company Participants Matt Steinberg - Investor Relations, Lazar Partners Steven Sherman - Chairman and Chief Executive Officer Scott Davis - President and Chief Operating Officer Bill Shaw - Chief Commercial Officer Jack Glenn - Chief Financial Officer Conference Call Participants Swayampakula Ramakanth - H.C. Wainwright & Co. Operator Greetings. Welcome to the Ekso Bionics Fourth Quarter 2021 Fin ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 001-37854 Ekso Bionics Holdings, Inc. (Exact name of registrant as specified in its charter) Nevada 99-0367049 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Emp ...

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q3 2021 Earnings Conference Call November 2, 2021 4:30 PM ET Company Participants Matt Steinberg - Lazar Partners Jack Peurach - President, CEO & Director William Shaw - Chief Commercial Officer John Glenn - CFO & Secretary Conference Call Participants Swayampakula Ramakanth - H.C. Wainwright & Co. Operator Greetings. Welcome to the Ekso Bionics Third Quarter 2021 Financial Results Conference Call. [Operator Instructions]. Please note, this conference is being recor ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________________________________________________________ FORM 10-Q ____________________________________________________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT ...

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q2 2021 Results Conference Call July 29, 2021 4:30 PM ET Company Participants Matt Steinberg - Investor Relations-Lazar Finn Partners Jack Peurach - President and CEO Jack Glenn - Chief Financial Officer Bill Shaw - Chief Commercial Officer Conference Call Participants RK Ramakanth - H.C. Wainwright Operator Greetings. Welcome to the Ekso Bionics Second Quarter 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A questi ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________________________________________________________ FORM 10-Q ____________________________________________________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 19 ...

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q1 2021 Earnings Conference Call April 29, 2021 4:30 PM ET Company Participants Matt Steinberg - Investor Relations-Lazar Finn Partners Jack Peurach - President and CEO Jack Glenn - CFO Bill Shaw - Chief Commercial Officer Conference Call Participants RK - H.C. Wainwright Operator Hello, and welcome to the Ekso Bionics First Quarter 2021 Financial Results Conference Call and Webcast. At this time, all participants are in a listen-only mode. A question-and-answer ses ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________________________________________________________ FORM 10-Q ____________________________________________________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1 ...

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q4 2020 Earnings Conference Call February 25, 2020 4:30 PM ET Company Participants Matt Steinberg – Investor Relations-Lazar Finn Partners Jack Peurach – President and Chief Executive Officer Bill Shaw – Chief Commercial Officer Jack Glenn – Chief Financial Officer Conference Call Participants Sean Kang – H.C. Wainwright Operator Greetings, and welcome to Ekso Bionics' Fourth Quarter 2020 Financial Results Call. [Operator Instructions] As a reminder, this conference ...